These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 39234449)

  • 1. The Romanian translation and validation of the Extended Prostate Cancer Index Composite in patients undergoing radical prostatectomy.
    Juravle IB; Hiriscau EI; Coroi T; Feciche BO; Crisan N; Coman I; Pop CD
    Med Pharm Rep; 2024 Jul; 97(3):330-337. PubMed ID: 39234449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The German version of the Expanded Prostate Cancer Index Composite (EPIC): translation, validation and minimal important difference estimation.
    Umbehr MH; Bachmann LM; Poyet C; Hammerer P; Steurer J; Puhan MA; Frei A
    Health Qual Life Outcomes; 2018 Feb; 16(1):36. PubMed ID: 29458434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portuguese version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP): psychometric validation and prospective application for early functional outcomes at a single institution.
    Lourenço DB; Amaral BS; Alfer-Junior W; Vasconcellos A; Russo F; Sanchez-Salas R; Bianco B; Wagner AA; Chang P; Moschovas MC; Lemos GC; Carneiro A
    BMC Urol; 2020 Oct; 20(1):163. PubMed ID: 33081748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors.
    Szymanski KM; Wei JT; Dunn RL; Sanda MG
    Urology; 2010 Nov; 76(5):1245-50. PubMed ID: 20350762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the French-Canadian version of the Expanded Prostate Cancer Index Composite (EPIC) in a French-Canadian population.
    Vigneault É; Savard J; Savard MH; Ivers H; Després P; Foster W; Martin AG; Fradet V
    Can Urol Assoc J; 2017 Dec; 11(12):404-410. PubMed ID: 29106365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.
    Anota A; Mariet AS; Maingon P; Joly F; Bosset JF; Guizard AV; Bittard H; Velten M; Mercier M
    Health Qual Life Outcomes; 2016 Dec; 14(1):168. PubMed ID: 27923377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.
    Wei JT; Dunn RL; Litwin MS; Sandler HM; Sanda MG
    Urology; 2000 Dec; 56(6):899-905. PubMed ID: 11113727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Italian version of the abbreviated expanded prostate Cancer index composite (EPIC-26) in men with prostate Cancer.
    Marzorati C; Monzani D; Mazzocco K; Masiero M; Pavan F; Monturano M; Pravettoni G
    Health Qual Life Outcomes; 2019 Aug; 17(1):147. PubMed ID: 31464649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of the korean version of expanded prostate cancer index composite: questionnaire assessing health-related quality of life after prostate cancer treatment.
    Chung KJ; Kim JJ; Lim SH; Kim TH; Han DH; Lee SW
    Korean J Urol; 2010 Sep; 51(9):601-12. PubMed ID: 20856644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Brazilian version of the Expanded Prostate Cancer Index Composite (EPIC) for patients submitted to radical prostatectomy.
    Alves E; Medina R; Andreoni C
    Int Braz J Urol; 2013; 39(3):344-52. PubMed ID: 23849583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quality of life in patients with prostate cancer: validation of an instrument for clinical practice].
    Balbontín F; Marchetti P; Moreno S; Cabello JM; Urzúa C; Silva A; Avilés J; Badínez L; García J; Salgado A; Vinez E; Alliende I; Canals A; Velasco A
    Arch Esp Urol; 2015 Jun; 68(5):466-73. PubMed ID: 26102050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain.
    Zapatero A; Maldonado Pijoan X; Gómez-Caamaño A; Pardo Masferrer J; Macías Hernández V; Hervás Morón A; Muñoz García JL; Palacios Eito A; Anguita-Alonso P; González-Junco C; López Torrecilla J
    Health Qual Life Outcomes; 2021 Sep; 19(1):223. PubMed ID: 34563208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26).
    Fosså SD; Storås AH; Steinsvik EA; Myklebust TA; Eri LM; Loge JH; Dahl AA
    Scand J Urol; 2016 Aug; 50(4):280-5. PubMed ID: 27049891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric validation of the Spanish version of the Expanded Prostate Cancer Index Composite-26.
    Zamora V; Garin O; Suárez JF; Jové J; Castells M; Ferrer F; Gutiérrez C; Guedea F; Boladeras A; Fumadó L; Roselló A; Pastor J; Samper P; Pont À; Ferrer M
    World J Urol; 2023 Dec; 41(12):3511-3518. PubMed ID: 37947846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric validation of the German version of the EPIC-26 questionnaire for patients with localized and locally advanced prostate cancer.
    Sibert NT; Dieng S; Oesterle A; Feick G; Carl G; Steiner T; Minner J; Roghmann F; Kaftan B; Zengerling F; Hinkel A; Beyer B; Heidenreich A; Harke N; Brehmer B; Pfitzenmaier J; Fichtner J; Neisius A; Hammerer P; Wesselmann S; Kowalski C
    World J Urol; 2021 Jan; 39(1):11-25. PubMed ID: 31552467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the measurement properties of the 26-item Expanded Prostate Cancer Index Composite (EPIC-26) with a multicenter cohort.
    Crump RT; Peterson A; Charbonneau C; Carlson KV; Sutherland JM; Baverstock RJ
    Can Urol Assoc J; 2020 Apr; 14(4):111-117. PubMed ID: 31702548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the quality of life of patients with localizad prostate cancer: validation of the Spanish version of the EPIC].
    Ferrer M; Garin O; Pera J; Prats JM; Mendivil J; Alonso J; De Paula B; Herruzo I; Hervas A; Macias V; Mariño A; Ortiz MJ; Pastor S; Ponce De León J; Sancho G;
    Med Clin (Barc); 2009 Feb; 132(4):128-35. PubMed ID: 19211071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cultural adaptation and validation of the Chinese version of the expanded prostate cancer index composite.
    Lee TK; Poon DMC; Ng ACF; Ho T; Singh-Carlson S; Joffres M; Oshan G; Kohli J; Kwan W
    Asia Pac J Clin Oncol; 2018 Mar; 14 Suppl 1():10-15. PubMed ID: 29508938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creation and validation of the harmonized Arabic version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP).
    Awad MA; Hallgarth L; Barayan GA; Shahait M; Abu-Hijlih R; Farkouh A; Azhar RA; Alghamdi MM; Bugis A; Yaiesh S; Aldousari S; Barham A; Saed M; Moussa A; Hassen W; Naud S; Plante MK; Grunert R
    Arab J Urol; 2022; 20(2):88-93. PubMed ID: 35530568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric Assessment of the Chinese Version of the Abbreviated Expanded Prostate Cancer Index Composite (EPIC-26) and the Clinical Practice Version (EPIC-CP) in Chinese Men With Prostate Cancer.
    Lam WWT; Tse MA; Ng CNL; Chung EKM; Fielding R
    J Pain Symptom Manage; 2017 Jun; 53(6):1085-1090. PubMed ID: 28438583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.